Cellectar reports financial results for second quarter 2023 and provides a corporate update

Florham park, n.j., aug. 14, 2023 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced financial results for the second quarter ended june 30, 2023 and provided a corporate update.
CLRB Ratings Summary
CLRB Quant Ranking